Publications by authors named "Steve Maton"

Claim this Profile
S
Similar rivastigmine pharmacokinetics and pharmacodynamics in Japanese and white healthy participants following the application of novel rivastigmine patch.
Gilbert Lefèvre, Monika Büche, Greg Sedek, Steve Maton, Albert Enz

J Clin Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketoconazole increases fingolimod blood levels in a drug interaction via CYP4F2 inhibition.
John M Kovarik, Kiran Dole, Gilles-Jacques Riviere, Francoise Pommier, Steve Maton

J Clin Pharmacol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects.
John M Kovarik, Alan Slade, Gilles-Jacques Riviere, Daniel Neddermann, Steve Maton

Br J Clin Pharmacol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
John M Kovarik, Michael Lu, Gilles-Jacques Riviere, Irene Barbet, Steve Maton

Eur J Clin Pharmacol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod.
John M Kovarik, Gilles-Jacques Riviere, Daniel Neddermann, Steve Maton, Thomas L Hunt

J Clin Pharmacol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis